Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The MD Anderson Cancer Center Spain Foundation is a non-profit organization dedicated to the research, prevention, and treatment of cancer, serving as the research arm of MD Anderson Cancer Center Madrid. As the first international affiliate of the University of Texas MD Anderson Cancer Center, the Foundation bridges the gap between clinical practice and scientific discovery through a robust clinical trials program. It specializes in early-phase drug development and translational research, participating in numerous international studies across a wide range of oncological indications. The Foundation also focuses on professional education and public health initiatives to improve cancer awareness and care standards in Spain. By collaborating with global pharmaceutical and biotech companies, it provides patients with access to innovative therapeutic modalities and personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MD Anderson Cancer Center Spain Foundation.